AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionBaader Bank INC
Latest Disclosed Ownership7,380 shares
Latest Disclosed Value $ 1,587,680
Baader Bank INC reports 560.70% increase in ownership of 4AB / AbbVie Inc.

On May 8, 2026 - Baader Bank INC filed a 13F-HR form disclosing ownership of 7,380 shares of AbbVie Inc. (BG:4AB) valued at $1,587,680 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 1,117 shares of AbbVie Inc.. This represents a change in shares of 560.70% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ABBVIE COM 00287Y109 7,380 6,263 560.70 1,588 524.80 0.1240
2026-02-05 2025-12-31 13F ABBVIE COM 00287Y109 1,117 -1,935 -63.40 254 -64.02 0.0175
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 3,052 -700 -18.66 707 5.69 0.0459
2025-07-10 2025-06-30 13F ABBVIE COM 00287Y109 3,752 1,044 38.55 668 18.65 0.0480
2025-05-08 2025-03-31 13F ABBVIE COM 00287Y109 2,708 792 41.34 564 65.59 0.0422
2025-01-23 2024-12-31 13F ABBVIE COM 00287Y109 1,916 -2,300 -54.55 340 -51.22 0.0222
2024-10-29 2024-09-30 13F ABBVIE COM 00287Y109 4,216 2,908 222.32 698 211.16 0.0408
2024-07-17 2024-06-30 13F ABBVIE COM 00287Y109 1,308 1,308 224 0.0142
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 0 -13,300 -100.00 0 -100.00
2023-05-04 2022-09-30 13F/A-1 ABBVIE COM 00287Y109 13,300 0 0.00 1,785 -12.42 0.1150
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 13,300 0 1,785 0.1518
2022-08-11 2022-06-30 13F ABBVIE COM 00287Y109 13,300 -74,522 -84.86 2,037 -85.69 0.1569
2022-09-06 2022-03-31 13F/A-1 ABBVIE COM 00287Y109 87,822 0 0.00 14,237 19.73 1.1404
2022-05-18 2022-03-31 13F ABBVIE COM 00287Y109 87,822 0 14,237 1.1404
2022-09-06 2021-12-31 13F/A-1 ABBVIE COM CL 2 00287Y109 87,822 87,822 11,891 0.9139
2022-05-17 2021-12-31 13F ABBVIE COM CL 2 00287Y109 87,822 87,822 11,891 0.9139
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.